Development of a Multiplexed Sphingolipids Method for Diagnosis of Inborn Errors of Ceramide Metabolism.

MLA

Byeon, Seul Kee, et al. “Development of a Multiplexed Sphingolipids Method for Diagnosis of Inborn Errors of Ceramide Metabolism.” Clinical Chemistry, vol. 70, no. 11, Nov. 2024, pp. 1366–74. EBSCOhost, https://doi.org/10.1093/clinchem/hvae115.

APA

Byeon, S. K., Kim, J., Wegwerth, P. J., Zenka, R., George, J. P., Pinto E Vairo, F., Oglesbee, D., Schultz, M. J., Matern, D., & Pandey, A. (2024). Development of a Multiplexed Sphingolipids Method for Diagnosis of Inborn Errors of Ceramide Metabolism. Clinical Chemistry, 70(11), 1366–1374. https://doi.org/10.1093/clinchem/hvae115

Chicago

Byeon, Seul Kee, Jinyong Kim, Peter Jared Wegwerth, Roman Zenka, John P George, Filippo Pinto E Vairo, Devin Oglesbee, Matthew J Schultz, Dietrich Matern, and Akhilesh Pandey. 2024. “Development of a Multiplexed Sphingolipids Method for Diagnosis of Inborn Errors of Ceramide Metabolism.” Clinical Chemistry 70 (11): 1366–74. doi:10.1093/clinchem/hvae115.